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During development, the proximal and distal regions of respiratory tract undergo distinct processes that ultimately give rise to conducting
airways and alveoli. To gain insights into the genetic pathways differentially activated in these regions when branching morphogenesis is
initiating, we characterized their transcriptional profiles in murine rudiments isolated at embryonic (E) day 11.5. By using oligonucleotide
microarrays, we identified 83 and 128 genes preferentially expressed in branching and non-branching regions, respectively. The majority of
these genes (85%) had not been previously described in the lung, or in other organs. We report restricted expression patterns of 22 of these
genes were by in situ hybridization. Among them in the lung potential components of the Wnt, TGF beta, FGF and retinoid pathways
identified in other systems, and uncharacterized genes, such as translocases, small GTPases and splicing factors. In addition, we provide a
more detailed analysis of the expression pattern and regulation of a representative gene from the distal (transforming growth factor, beta
induced) and proximal (WW domain-containing protein 2) regions. Our data suggest that these genes may regulate focal developmental
events specific of each of these regions during respiratory tract formation.
D 2004 Elsevier Inc. All rights reserved.Keywords: Lung development; Microarrays; Branching morphogenesis; Respiratory tract; Growth factors; TGF beta; Tgfbi; Wwp2; Ubiquitination; Retinoic
acidIntroduction
Development of the respiratory tract involves formation
of the tracheobronchial tree and the alveoli; for most species
this process spans the embryonic (E) and postnatal periods of
life. In mice, primary lung buds and the tracheal primordium
emerge independently from the primitive foregut at E9.5.
Secondary lung buds appear a day later, and by E11–11.5
they branch to give rise to multiple generations of airways.
Concurrently, both epithelial and mesenchymal components
of these airways undergo proximal–distal (P–D) differenti-
ation. Proximal regions will form the conducting airways,
while the distal regions of the branching tubules will generate
the future alveoli (reviewed in Cardoso, 2001; Hogan, 1999).
Tissue recombination experiments in embryonic mouse
or rat models have shown that distal lung mesenchyme is0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: wcardoso@lung.bumc.bu.edu (W.V. Cardoso).able to induce budding and distal gene expression in the
developing proximal epithelium (Ohtsuka et al., 2001;
Shannon et al., 1998; Wessells, 1970). Differences in the
morphogenetic potential of proximal and distal regions of
the respiratory tract are evident from the earliest develop-
mental stages. These ultimately reflect differences in the
repertoire of signaling molecules present in epithelial and
mesenchymal cells along the developing respiratory tract.
There is evidence that during early branching morpho-
genesis a distal signaling network is established in the E11–
12 mouse lung to maintain proper growth and proximal–
distal differentiation. For example, distal epithelial buds
require local signaling by mesenchymal fibroblast growth
factor Fgf10 for proper induction, while epithelial sonic
hedgehog (Shh) and bone morphogenetic protein-4 (Bmp4)
act as negative regulators of this process (reviewed in
Cardoso, 2001; Hogan, 1999). By contrast, the proximal
non-branching region (main bronchi and trachea) is consid-
ered to be morphogenetically less active, proliferating less
and starting cellular differentiation earlier (Mollard and
Dziadek, 1998). Sites where the proximal mesenchyme will
Fig. 1. Diagram illustrates the strategy for sampling of the respiratory tract of
E11.5 mouse. The branching region consisted of the right and left lung. Non-
branching region included themain bronchi and the lower third of the trachea.
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already at E11.5 by local expression of retinoic acid receptor
gamma (Rarc), a critical regulator of this process (Mollard et
al., 2000b). In addition to regionally expressed regulatory
molecules, extracellular matrix (ECM), cell adhesion mole-
cules and even structural molecules are also part of local
networks that influence local cellular behavior. Identifying
global patterns of gene expression in proximal and distal
regions is critical to understand how these differences in
cellular behavior and phenotypes arise.
Recently, genome-wide discovery tools in combination
with large scale in situ hybridization screen have been used
to identify genes expressed in a temporal and spatial-specific
fashion in a variety of developmental processes (Butler et al.,
2003; Stathopoulos et al., 2002; White et al., 1999). Similar
approaches have been used to examine expression profiles
during lung development. One of these studies examined
whole lungs at different developmental stages (Mariani et al.,
2002), while others have focused on genes expressed are an
individual germ layer (Liu and Hogan, 2002) or reported a
particular regionally expressed gene (Lin and Shannon,
2002).
Here, we used oligonucleotide microarrays to character-
ize the transcriptional profile of proximal and distal regions
of the mouse respiratory tract at E11.5, when branching
morphogenesis is initiating. We compared two regions with
largely different morphogenetic potentials to gain insights
into the pathways that potentially distinguish proximal non-
branching from the distal branching region. We provide a
complete list of the microarray data, which show little
overlap with previously published data. We report the
spatial distribution of 22 previously uncharacterized genes.
We show that the proximal region is enriched for genes
encoding components of the RA pathway, ECM molecules
that favor morphogenetic stabilization, including various
procollagen genes and SRY-box transcription factors. In
the distal region we found potential components of the
Wnt, TGF beta and FGF signaling and other pathways
reported elsewhere, but not in the lung. Some of these
genes, such as translocases and splicing factors, were highly
specific for the distal mesenchyme. From this survey we
selected a representative distal (transforming growth factor,
beta induced) and a proximal (WW domain-containing
protein 2) gene for further analysis because of their unique
expression pattern, which suggested a role in regulating
specific events locally.Material and methods
Lung dissection, RNA isolation, labeling and microarray
hybridization
Lungs and lower third of trachea were dissected from the
E11.5 CD1 mouse embryos. Branching and non-branching
regions of the lung were separated as illustrated in Fig. 1.Both right and left lungs were included for the analysis of
the branching region. Total RNA from these samples was
isolated using RNeasy (Qiagen) and then subjected to
labeling and hybridization using the Affymetrix kit accord-
ing to the manufacturer’s manual.
Microarray data analysis
Three arrays (Affymetrix, MG-U74v2 set) were used per
each experimental condition. A single weighted mean ex-
pression level for each gene along with a detection P value
(which indicates whether the transcript was reliably detected)
was derived using Microarray Suite 5.0 software (Affyme-
trix, Santa Clara, CA). We scaled the data from each array
(target intensity of 500) to normalize the results for inter-array
comparisons. The list of genes on this array is available at
http://www.affymetrix.com/analysis/download_center.affx.
All data from our microarray experiments have been depos-
ited in NCBI’s Gene Expression Omnibus; the accession
numbers for the samples are: GSM23483, GSM23484,
GSM23485, GSM23486, GSM23487, GSM23488.
Each array’s scanned image was examined for significant
artifacts and the bacterial genes spiked into the hybridization
mix had a detection P value below 0.05 (called present). In
addition, several quality control metrics were assessed on
each array. Background signals were within the recommen-
dation limit (less than 100). The scaling factors used to
normalize the target value ranged from 0.71 to 1.38 (within
4-fold standard limit). The 3V/5V ratios of Gapdh and beta-
actin ranged from 0.86 to1.75 (lower than the four fold
standard limit). Genes with detection P values greater than
0.05 (called absent) in all six samples were eliminated from
our analysis (55% in our case). A Student’s t test was
performed to identify genes differentially expressed between
regions. Genes were considered differentially expressed if
their fold change (FC) was greater than 1.75 with P value (on
Student’s t test) lower than 0.05. This combined statistical
and fold change threshold helped us to focus on those genes
with most significant changes and excluded potential artifi-
Table 1
Branching region-enriched genes
Accession no. Protein encoded/homolog Fold change Rank Expression
pattern/reference
Cell adhesion and extracellular matrix proteins
M62470 thrombospondin 1 2.72 15 Liu and Hogan, 2002
L19932 transforming growth factor, beta induced, 68 kDa 2.33 24 Figs. 4A–I
AJ012160 trophoblast glycoprotein 1.86 57 n.d.
AA683966 mucin and cadherin like 1.78 76 Fig. 2I
Ligand/receptor
D85028 semaphorin 3A 7.50 3 Kagoshima and Ito, 2001
AI848841 patched, shh receptor 2.47 21 Bellusci et al., 1997
X94322 melanoma inhibitory activity 2.15 29 Lin and Shannon, 2002
AF019046 tumor necrosis factor receptor superfamily, member 11a 2.03 37 n.d.
M64849 platelet-derived growth factor B chain 1.96 45 Han et al., 1992
Transcription factors
U84725 GATA binding protein 5 17.83 1 Morrisey et al., 1997
M26283 homeobox B5 6.52 4 Holland and Hogan, 1988
M61007 CCAAT/enhancer binding protein (C/EBP), beta 4.93 5 n.d.
M98502 zinc finger protein 46 3.65 7 n.d.
M18401 homeobox B6 3.35 8 Holland and Hogan, 1988
X95503 pleiomorphic adenoma gene-like 1 2.64 16 n.d.
X63190 ets variant gene 4 (E1A enhancer binding protein, E1AF) 2.50 19 Liu and Hogan, 2002
L35949 HNF-3/forkhead homolog 8 2.35 22 Peterson et al., 1997
AB009693 v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) 2.08 34 n.d.
U79550 snail homolog 2 (Drosophila) 1.99 42 Savagner et al., 1998
M12731 neuroblastoma myc-related oncogene 1 1.80 71 Moens et al., 1992
D87908 nuclear protein 95 1.77 79 n.d.
AK035172 zinc finger, DHHC domain containing 6 (Zdhhc6) 1.77 78 Fig. 2M
Retinoic related
AA790008 reduced expression 3 (Rex3) 2.35 23 Fig. 2O
Proteolysis
AI838669 proteasome 26S subunit, non-ATPase, 12 2.49 20 n.d.
AI838853 ubiquitin carboxyl-terminal esterase L5 2.31 25 n.d.
U43918 proliferation-associated 2G4, 38 kDa (Pa2g4) 2.01 39 Fig. 2F
AW120683 cell division cycle 34 homolog 1.82 67 n.d.
Ion channel
AV374320 similar to solute carrier family 4, sodium bicarbonate cotransporter, member 7 11.13 2 n.d.
X02677 solute carrier family 4 (anion exchanger), member 1 (Slc4a1) 1.83 64 Fig. 2P
Cytoskeleton proteins
AB011678 doublecortin 2.61 17 n.d.
X60671 villin 2 2.01 38 n.d.
AA184423 ectodermal-neural cortex 1 (Enc1) 1.96 46 Fig. 2E
U72519 Ena-vasodilator stimulated phosphoprotein 1.89 54 n.d.
AA867778 actinin, alpha 1 1.84 61 n.d.
Cell cycle regulators
AA756292 chromosome condensation 1 2.14 30 n.d.
X57800 proliferating cell nuclear antigen 1.84 59 n.d.
AI173038 chromatin assembly factor 1, subunit B 1.84 62 n.d.
AA856349 protein regulator of cytokinesis 1 1.81 70 n.d.
Metabolic enzymes
M25944 carbonic anhydrase 2 (CaII) 2.84 12 Fig. 2Q
AJ238213 exonuclease 1 2.21 27 n.d.
Y11666 hexokinase 2 2.13 31 n.d.
AW122030 phosphoserine aminotransferase 2.13 32 n.d.
M14223 ribonucleotide reductase M2 2.00 40 n.d.
U49350 cytidine 5V-triphosphate synthase 1.81 69 n.d.
AF059735 C-terminal binding protein 2 1.77 77 n.d.
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Accession no. Protein encoded/homolog Fold change Rank Expression
pattern/reference
Metabolic enzymes
AF031486 spermine synthase 1.75 83 n.d.
Kinase/phosphatase
AA285446 dual specificity phosphatase 9 (Dusp9) 2.75 14 Fig. 2G
M96163 serum-inducible kinase 2.60 18 n.d.
AI845584 dual specificity phosphatase 6 1.88 55 n.d.
GTPase signal pathway
AW123750 guanine nucleotide binding protein, gamma 2 subunit 2.82 13 n.d.
AW124226 GTP-binding protein Sara 2.07 35 n.d.
X02452 Kirsten rat sarcoma oncogene 2, expressed 1.84 63 n.d.
X89650 RAB7, member RAS oncogene family 1.79 74 Fig. 2H
AK14226 dedicator of cytokinesis 7 (Dock7) 2.06 36 Fig. 2L
Splicing factor
AW123909 RNA binding protein gene with multiple splicing 1.87 56 n.d.
X53824 splicing factor, arginine/serine-rich 3 (Sfrs3) 1.85 58 Fig. 2D
AW060546 splicing factor proline/glutamine rich (Sfpq) 1.76 82 Fig. 2C
Hemoglobin
J00413 hemoglobin, beta adult major chain 1.97 44 n.d.
X14061 hemoglobin Y, beta-like embryonic chain 1.92 48 n.d.
M13125 hemoglobin X, alpha-like embryonic chain in Hba complex 1.79 75 n.d.
V00714 hemoglobin alpha, adult chain 1 1.77 81 n.d.
Others
AA921489 surfactant associated protein C 3.33 9 Wert et al., 1993
U44088 pleckstrin homology-like domain, family A, member 1 3.02 11 n.d.
D85904 heat shock protein 4 2.21 26 n.d.
AA655369 translocase of inner mitochondrial membrane 8 homolog a (yeast) (Timm8a) 1.99 41 Fig. 2B
AF062378 calmodulin binding protein 1 1.97 43 n.d.
AF093853 antioxidant protein 2 1.92 47 n.d.
AW050268 HLA-B associated transcript 2 1.92 49 n.d.
AW048763 NMDA receptor-regulated gene 1 1.91 50 n.d.
AI843178 cerebellar postnatal development protein 1 1.90 51 n.d.
AW047032 protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1 1.90 52 n.d.
AF043249 translocase of outer mitochondrial membrane 40 homolog (yeast) (Tomm40) 1.90 53 Fig. 2A
ESTs
AK48222 4921526G09Rik 4.27 6 Fig. 2N
AV242583 2410002F01Rik 3.07 10 n.d.
AV334517 2010012D11Rik 2.17 28 n.d.
U21906 U21906 2.10 33 n.d.
AI122538 2810417H13Rik 1.84 60 n.d.
AW120606 Flana-pending 1.82 65 n.d.
C79329 C79329 1.82 66 Fig. 2J
AI853476 2610312E17Rik 1.82 68 n.d.
AK046712 B430320C24Rik 1.80 72 Fig. 2K
AW121031 D11Ertd175e 1.79 73 n.d.
AI847972 D130027G05Rik 1.77 80 n.d.
n.d. = not described.
Table 1 (continued)
J. Lu¨ et al. / Developmental Biology 273 (2004) 418–435 421cial differences that could arise from low level or undetect-
able level gene expression in all our samples. The GoMiner
software (Fish Exact T test, http://discover.nci.nih.gov/
gominer/) (Zeeberg et al., 2003) was used for statistical
measure of representation of gene categories enriched in
either the branching or non-branching regions. The list for
all genes on the chip (Affymetrix, MG-U74v2 set) was inputas the query gene file and each of the preferential expression
gene list as the query changed gene file. All the information
for three different categories in GO (Biological Process,
Molecular Function and Cellular Component) was down-
loaded as Excel files. Categories with P value lower than 0.01
were selected for analysis, while the redundant and some
subcategories were removed.
Table 2
Non-branching region-enriched genes
Accession No. Protein encoded/homolog Fold change Rank Expression pattern/reference
Cell adhesion and extracellular matrix proteins
D00613 matrix gamma-carboxyglutamate (gla) protein 4.41 11 Luo et al., 1995
X78445 astrotactin 1 3.71 13 n.d.
X56304 tenascin C 3.58 15 n.d.
M60523 osteoblast specific factor 2 (fasciclin I-like) 2.55 38 n.d.
D13664 vascular cell adhesion molecule 1 2.43 46 n.d.
D82029 cadherin 6 2.19 57 n.d.
AA763466 procollagen, type I, alpha 1 2.10 63 n.d.
AW212495 procollagen, type IX, alpha 3 2.06 66 n.d.
X58251 procollagen, type I, alpha 2 2.06 69 n.d.
Z18272 procollagen, type VI, alpha 2 1.94 81 n.d.
L07803 thrombospondin 2 1.85 95 Iruela-Arispe et al., 1993
U69176 laminin, alpha 4 1.81 103 n.d.
AF101164 CEA-related cell adhesion molecule 2 1.80 108 n.d.
AB024538 immunoglobulin superfamily containing leucine-rich repeat 1.77 119 n.d.
AA919594 elastin 2.91 26 n.d.
AW124007 matrilin 4 2.56 37 n.d.
L38971 integral membrane protein 2A 2.39 47 n.d.
AK003537 1110007F23Rik 2.26 52 Fig. 3A
M84487 odd Oz/ten-m homolog 3 (Drosophila) 2.12 60 n.d.
X75285 fibulin 2 1.91 87 Zhang et al., 1996
AB025413 odd Oz/ten-m homolog 4 (Drosophila) 1.86 91 n.d.
X53928 biglycan 1.79 111 n.d.
AA838868 latent transforming growth factor beta binding protein 4 1.78 118 Sterner-Kock, et al., 2002
Ligand and receptor
M89798 wingless-related MMTV integration site 5A (Wnt5a) 11.24 1 Li et al., 2002
D90225 pleiotrophin 3.20 20 Vanderwinden et al., 1992; Fig. 3C
AW125442 protein kinase inhibitor, alpha 2.97 25 n.d.
AI504074 G protein-coupled receptor 97 2.76 31 n.d.
U42467 leptin receptor 2.59 34 n.d.
D50086 neuropilin 2.23 54 Kagoshima and Ito, 2001
L12030 chemokine (C-X-C motif) ligand 12, beta 2.19 56 n.d.
L47480 bone morphogenetic protein 4 2.11 61 Weaver et al., 2003
L12029 chemokine (C-X-C motif) ligand 12, alpha 2.06 67 n.d.
AF014117 glial cell line derived neurotrophic factor family receptor alpha 1 2.06 68 n.d.
D31951 osteoglycin 1.92 82 n.d.
L38580 galanin 1.92 83 n.d.
D13903 protein tyrosine phosphatase, receptor type, D 1.88 89 n.d.
X80764 tyrosine kinase receptor 1 1.85 94 Taichman et al., 2003
U41341 S100 calcium binding protein A11 (calizzarin) 1.82 100 n.d.
U72634 unc5 homolog (C. elegans) 3 1.77 122 n.d.
Transcription factor
X74040 forkhead box C2 5.49 4 n.d.
M63649 twist gene homolog, (Drosophila) 5.23 6 n.d.
U48721 Zinc finger protein 60 2.83 27 n.d.
AF035717 transcription factor 21 2.61 33 Quaggin et al., 1999
U20282 transcription factor 20 2.52 39 n.d.
X94127 SRY-box containing gene 2 2.46 43 n.d.
Z97062 Sin3-associated polypeptide 18 2.45 45 n.d.
AW048640 inhibitor of DNA binding 3 2.17 58 n.d.
D70849 zinc finger protein of the cerebellum 3 2.14 59 n.d.
AJ010605 SRY-box containing gene 6 2.11 62 n.d.
U03873 paired related homeobox 1 2.09 64 n.d.
AF047389 SRY-box containing gene 10 2.07 65 n.d.
AI849939 5830413E08Rik 2.04 70 n.d.
U61362 transducin-like enhancer of split 1, homolog of Drosophila E (spl) 1.92 84 n.d.
AI837107 single-stranded DNA binding protein 2 1.83 97 n.d.
AI603944 B230354B21Rik 1.83 98 n.d.
Y07688 nuclear factor I/X 1.80 106 Fig. 3B
AI840267 sirtuin 2 homolog (S. cerevisiae) 1.80 109 n.d.
U92704 early B-cell factor 3 1.78 115 n.d.
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Table 2 (continued)
(continued on next page)
Accession No. Protein encoded/homolog Fold change Rank Expression pattern/reference
Transcription factor
L27453 pre B-cell leukemia transcription factor 1 1.76 126 n.d.
Retinoic acid related
M34476 retinoic acid receptor, gamma 5.36 5 Mollard et al., 2000b
X15789 cellular retinoic acid binding protein I 4.61 8 n.d.
AF062476 stimulated by retinoic acid gene 6 3.34 17 n.d.
AJ001616 myeloid-associated differentiation marker 1.91 86 n.d.
X95281 retinal short-chain dehydrogenase/reductase 1 1.75 127 n.d.
Proteolysis
AJ131851 cathepsin F 8.95 3 n.d.
AA921411 WW domain-containing protein 2 (Wwp2) 3.20 19 Figs. 5A–H
AI844932 F-box only protein 8 2.83 28 n.d.
AB025412 fibroblast activation protein 2.27 51 n.d.
AF077738 carboxypeptidase X 1 (M14 family) 1.95 80 n.d.
Z12604 matrix metalloproteinase 11 1.85 93 n.d.
J03520 plasminogen activator, tissue 1.77 120 n.d.
U48797 bone morphogenetic protein 1 1.75 128 Fukagawa et al., 1994
Ion channel
X81202 glycine receptor, beta subunit 1.95 79 n.d.
AF004666 solute carrier family 8 (sodium/calcium exchanger), member 1 1.92 85 n.d.
AV278013 solute carrier family 4, sodium bicarbonate cotransporter, member 7 1.87 90 n.d.
AF047838 chloride channel calcium activated 1 1.86 92 Gandhi et al., 1998
AF012871 potassium voltage-gated channel, subfamily H, member 2 1.81 102 n.d.
Cytoskeleton proteins
AV251191 filaggrin 9.92 2 n.d.
M83985 synaptosomal-associated protein, 91 kDa 4.66 7 n.d.
D85923 myosin heavy chain 11, smooth muscle 4.51 9 n.d.
U28932 calponin 1 3.63 14 Tollet et al., 2001
M15501 actin, alpha, cardiac 3.15 23 Tollet et al., 2001
AV213431 troponin T1, skeletal, slow 3.05 24 n.d.
X13297 actin, alpha 2, smooth muscle, aorta 2.47 41 n.d.
Z68618 transgelin 2.01 75 n.d.
AI641895 shroom 1.96 77 n.d.
L47600 troponin T2, cardiac 1.95 78 n.d.
AI849075 capping protein (actin filament), gelsolin-like 1.82 101 n.d.
Cell cycle regulators
L12447 insulin-like growth factor binding protein 5 2.56 36 van Kleffens et al., 1999
Y12474 centrin 3 2.20 55 n.d.
X65128 growth arrest specific 1 2.03 74 Lee et al., 2001
Metabolic enzymes
U92702 cytochrome P450, 1b1, benz[a]anthracene inducible 4.38 12 n.d.
AI854020 cysteine dioxygenase 1, cytosolic 3.16 21 n.d.
AW048512 enoyl Coenzyme A hydratase, short chain, 1, mitochondrial 1.85 96 n.d.
AF011336 ATPase, class II, type 9A 1.83 99 n.d.
AF023463 phytanoyl-CoA hydroxylase 1.76 125 n.d.
GTPase signal pathway
AJ007971 interferon-inducible GTPase 3.16 22 n.d.
AW121127 ras homolog gene family, member J 2.45 44 n.d.
U96634 Rho guanine nucleotide exchange factor (GEF7) 1.80 104 n.d.
AB020741 Nik related kinase 1.80 107 n.d.
Others
D21165 visinin-like 1 3.41 16 n.d.
L04961 inactive X specific transcripts 2.80 29 n.d.
AA980164 SPARC related modular calcium binding 2 2.77 30 n.d.
M14044 annexin A2 2.58 35 n.d.
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Accession No. Protein encoded/homolog Fold change Rank Expression pattern/reference
Others
U59282 F1F0 ATP synthase E subunit 2.46 42 n.d.
U13371 kidney cell line derived transcript 1 2.03 73 Tymms et al., 1997
AB026808 synaptotagmin 11 2.01 76 n.d.
U12566 Defensin related cryptdin, related sequence 12 1.80 105 n.d.
Y08361 reversion induced LIM gene 1.78 112 n.d.
X78989 testis derived transcript 1.78 116 n.d.
AJ001633 annexin A3 1.76 123 n.d.
AF027707 Bcl-2-related ovarian killer protein 1.76 124 n.d.
ESTs
AV305843 1110062M06Rik 4.44 10 n.d.
AI842065 AI842065 3.21 18 n.d.
AA518586 5530400H20Rik 2.68 32 n.d.
AV376312 4930422J18Rik 2.49 40 n.d.
AI596360 4930422J18Rik 2.37 48 n.d.
AA260139 Emu2-pending 2.30 49 n.d.
AW124049 D5Ertd593e 2.29 50 n.d.
AV366654 1110007F23Rik 2.26 53 n.d.
AW045417 1110007H17Rik 2.04 71 n.d.
AI851387 5830436L09Rik 2.04 72 n.d.
AI843106 1110002G11Rik 1.89 88 n.d.
Y10007 1500041O16Rik 1.79 110 n.d.
AW046101 D8Ertd594e 1.78 113 n.d.
AI853573 AI853573 1.78 114 n.d.
AW125223 2410002J21Rik 1.78 117 n.d.
AA575098 D930018N21Rik 1.77 121 n.d.
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For the lung organ cultures, E11–12 lungs from CD1
mice, or in some experiments, from RARE lacZ transgenic
mice (Rossant et al., 1991) were dissected and placed onto
MF-Millipore membrane filters (Whatman), on the top of a
metal mesh on tissue culture dish, and cultured in BGjb
medium (Sigma 20 mg/100 ml of ascorbic acid, 1% of
inactivated fetal calf serum and 50 units/Ag penicillin/strep-
tomycin). For some experiments, TGFh1 (human recombi-
nant, 10–50 ng/ml, R&D system), retinoic acid (106 or 105
M, Sigma) or BMS493 (106M, Bristol-Myers-Squibb) were
added to the medium at the beginning of the culture, as
previously described (Malpel et al., 2000; Mollard et al.,
2000a; Serra et al., 1994). Lung explants were harvested at 24
and 48 h, fixed in 4% paraformaldehyde and processed for
whole mount in situ hybridization.
In situ hybridization
All cDNA clones used for probe labeling were from NIA
Mouse 15K cDNA Clone Set, distributed by the Microarray
Core Facility in Tufts University School of Medicine. The
accession numbers for the cDNA clones are: Enc1
(BG062990), Tomm40 (BG063919), Pa2g4 (BG064819),
Rex3 (BG064920), AK48222 (BG066249), C79329
(BG066485), AK046712 (BG066982), AK014226
(BG067751), AK035172 (BG070966), Tgfbi (BG072750),
Rab7 (BG074292), Sfpg (BG068503), Wwp2 (BG072455),
n.d. = not described.Ptn (BG073550), AK 003537 (BG074573), Nfix
(BG075770); AK007899 (BG063646); The cDNA inserts
with SP6 promoter region were amplified by PCR using M13
primers. The DNA templates for the following genes were
generated by PCR with the primers that have either T7 or T3
promoters. The primer sequences are:Dusp9 forward primer:
5V- AATTAACCCTCACTAAAGG CCTGTGCTTGAGCT-
CTGATT-3V, Dusp9 backward primer: 5V- TAATACGACT-
CACTATAGG GAGTGAGAGGTGAAGCTTCT-3V;
Timm8a forward primer: 5V-AATTAACCCTCACT-
AAAGGG CTATGGAGTGTTCCTGCAAT-3V, Timm8a
backward primer: 5V-TAATACGACTCACTATAGGG ATG-
GAATCGATGTCTACCAT-3V; CaII forward primer: AAT-
TAACCCTCACTAAAGGG CCATATGAAGGTAGGA-
TAAT, CaII backward primer: TAATACGACTCACTATA-
GGG ATTGTGTTGTGGTATGTTAT; Srp20 forward
primer: AATTAACCCTCACTAAAGGG CAGAGC-
TATTGTAACGTCT, Srp20 backward primer: TAATAC-
GACTCACTATAGGG GACTTGATACCAAGCTCAC;
Slc4a1 forward primer: AATTAACCCTCACTAAAGGG
GAACTAGAACTTGTGAGAGA, Slc4a1 backward
primer: TAATACGACTCACTATAGGG ACAGA-
CACGTTTATTGGCAA. PCR products were purified
and used as template for probe labeling. DIG-labeled
RNA probes were generated using the appropriate RNA
polymerase, as described on the manufacturer’s manual
(Ambion). The quality of labeled RNA probes was
assessed by gel electrophoresis. Whole mount in situ
hybridization of freshly isolated E9.5–13 lungs or lung
J. Lu¨ et al. / Developmental Biology 273 (2004) 418–435 425cultures was performed in 96-well plates as previously
described (Wertz and Herrmann, 2000).
Western blotting
Protein extracts from trachea and proximal regions of
cultured lung explants (control, all-trans-RA 106 M; n = 4
for each condition) were loaded for gel electrophoresis, then
transferred onto nitrocellulose membrane, blocked with 5%
milk in TBST and incubated overnight with RARg antibody
(rabbit polyclonal antibody, Bioreagents, 1:2000) in TBST
with 5% of milk. Immuno-Star HRP Chemiluminescent kit
(Bio-rad) was used for secondary antibody reaction and
signal development according to manufacturer’s protocol.
The membrane was stripped after RARg detection and then
re-probed with anti a-tubulin antibody (1:5000, Sigma)
following the same protocol.Results and discussion
This study was designed to characterize the differences in
the transcriptional profile of the branching vs. non-branching
regions of the E11.5 mouse respiratory tract. We focused on
E11.5 because (1) this represents one of the earliest stages in
which the respiratory and the digestive tract have been
completely separated; (2) all lobes are clearly identified and
branching morphogenesis has just initiated; and (3) while a
P–D axis has been already defined, epithelial tubules have
not undergone terminal differentiation and are still able to be
re-specified, as shown by grafting studies(Ohtsuka et al.,
2001; Wessells, 1970).
Validation of the array data
From the 12,500 known or predicted genes present on the
array (Murine U74A v2, Affymetrix) we found 83 genes
enriched in the branching region, and 128 genes enriched in
non-branching region (FC > 1.75, P < 0.05; Tables 1 and 2).
The microarray data were validated by comparing the results
with published gene expression patterns in E11–12 lungs,
and by performing whole mount in situ hybridization of the
genes whose expression in the lung had not previously
characterized.
The majority of the genes identified in our survey had not
been formerly described in the embryonic lung. We found
that only 15% of the transcripts (13 out of 83) enriched in the
branching region were previously reported in the distal lung
(Table 1 and references therein). These included the distal
lung marker Surfactant protein C (Sp-C) (Wert et al., 1993),
the transcription factors Pcna (proliferating cell nuclear
antigen), N-myc, Foxf1a, Hoxb5 and b6, GATA5, Etv4(Pea3)
and Snail (slug) (Holland and Hogan, 1988; Lim et al., 2002;
Liu and Hogan, 2002; Moens et al., 1992; Morrisey et al.,
1997; Savagner et al., 1998), the signalingmoleculesPatched
(receptor of Shh), Semaphorin 3A, platelet-derived growthfactor B and the extracellular glycoprotein thrombospondin 1
(Bellusci et al., 1997; Han et al., 1992; Kagoshima and Ito,
2001; Liu and Hogan, 2002).
For the transcripts enriched in the non-branching re-
gion, 13% (17 out of 128) had already been reported in
proximal lung (Table 2 and references therein). These
included the transcription factors Pod1 (zinc finger protein
21), Rarc, Wnt5a, and pleiotrophin and its receptor
(protein tyrosine phosphatase, receptor type, D)(Li et
al., 2002; Lohnes et al., 1993a; Mollard et al., 2000b;
Quaggin et al., 1999; Vanderwinden et al., 1992), the cell
adhesion molecules thrombospondin 2 and Gla; and
cytoskeleton molecules such as Calponin 1, Cardiac
alpha actin (Iruela-Arispe et al., 1993; Luo et al., 1995;
Tollet et al., 2001).
By in situ hybridization we confirmed proximal expres-
sion of four out of the five uncharacterized genes from the
non-branching region, and distal expression of 18 out of 19
uncharacterized genes from the branching region. The
overall agreement of our array data with published expres-
sion patterns and in situ hybridization results suggested that
this approach reliably detects regional differences in gene
expression in the E11.5 lung.
Factors influencing the outcome of the array data
We asked whether the proportion of epithelial to mesen-
chymal cells was markedly different in proximal and distal
regions to bias the interpretation of the array data. This did
not seem to be the case, since epithelial cytokeratins (Endo
A and Endo B) and mesenchymal vimentin genes were not
differentially enriched in any of the regions (P = 0.69 for
Endo A; P = 0.52 for Endo B; P = 0.26 for vimentin).
Moreover, in situ hybridization analysis showed that mes-
enchymal and epithelial genes were well represented in the
gene lists from both regions.
We used the GoMiner Bioinformatics tool to find the
representation of GO biological process categories in the
gene lists originated from our screen (Zeeberg et al.,
2003). We found that the category associated with cell
cycle and cell proliferation was the sole category over-
represented in the branching region. This was consistent
with the increased proliferation activity of the distal lung.
Analysis of the gene list from the non-branching region
revealed that the categories overrepresented were associ-
ated with catalytic and proteolytic activities, smooth
muscle formation and muscle contraction, extracellular
matrix deposition, cell motility, extracellular matrix and
cell adhesion (all at P < 0.01). These reflect the specific
developmental events that occur in the more morphoge-
netically stable proximal regions. The low number of
categories overrepresented in the distal region was some-
what surprising, since progenitor cells in the distal lung
are expected to be more diverse and, thus, activate
multiple genetic pathways. Presumably these genes could
not be consistently detected by the microarray because
J. Lu¨ et al. / Developmental Bio426their expression levels were too low or because they may
have been restricted to a small population of cells. For
example, Fgf10 transcripts were not detectable in our
array. Bmp4, which is dynamically expressed in distal
epithelium and in proximal and distal mesenchyme, was
found enriched in proximal samples(Weaver et al., 2003).Fig. 2. Expression pattern of genes enriched in branching region (arrowheads) o
consisted of genes expressed in the distal mesenchyme: (A) translocase of outer
mitochondrial membrane 8 homolog a (Timm8a); (C) splicing factor proline/glutam
(E) ectodermal-neural cortex 1 (Enc1); (F) proliferation-associated 2G4, 38 kDa (P
oncogene family (Rab7). Group II represents the genes expressed in both distal m
(C79329); (K) EST (AK046712); (L) dedicator of cytokinesis 7 (Dock7). Grou
containing 6 (Zdhhc6); (N) EST (AK48222); (O) reduced expression 3 (Rex3). G
(anion exchanger), member 1 (Slc4a1, see also high magnification on the right);Identification of genes differentially expressed in the
branching region
In situ hybridization analysis of the 18 previously unchar-
acterized genes enriched in the branching region revealed
three major patterns of transcript distribution.
logy 273 (2004) 418–435f E11.5 mouse lung by whole mount in situ hybridization (ISH). Group I
mitochondrial membrane 40 homolog (Tomm40); (B) translocase of inner
ine rich (Sfpq); (D) splicing factor, arginine/serine-rich 3 (Srp20 or Sfrs3);
a2g4); (G) dual specificity phosphatase 9 (Dusp9); (H) Rab7, member RAS
esenchyme and epithelium: (I) mucin and cadherin like (Mucdhl); (J) EST
p III are distal epithelial-specific genes: (M) zinc finger, DHHC domain
roup IV includes genes expressed in blood cells: (P) solute carrier family 4
(Q) carbonic anhydrase 2 (CaII). Scale bar in A represents 250 AM.
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mesenchyme. There were eight genes in this group: two
translocases (Tomm40 and Timm8a), two splicing factors
(Sfpq and Sfrs3), Enc1, Pa2g4, Dusp9 and Rab7.
Tomm40 (translocase of outer mitochondrial membrane
40 homolog) (Suzuki et al., 2000) and Timm8a (translocase
of inner mitochondrial membrane 8 homolog) are mouse
gene homologous of two yeast translocases(Figs. 2A and
B). Timm8a is mutated in Deafness Dystonia Syndrome
(MTS/DFN-1); its interaction with Signal Transduction
Adaptor Molecule-1 (STAM1) has been reported. STAM1
is involved in cytokine signaling activity by interacting with
Janus kinase (Blackstone et al., 2003; Roesch et al., 2002).
The restricted expression of two members of this family in
overlapping domains of the distal mesenchyme is intriguing
and suggests a potential role in intracellular transport of
proteins.
Sfpq (splicing factor proline/glutamine rich) is a nuclear
protein with multiple functions, including RNA splicing,
transcriptional regulation and tumorigenesis (Fig. 2C)
(Shav-Tal and Zipori, 2002). Sfsr3 (similar to Splicing
factor, arginine/serine-rich 3, also known as Srp20) has
multiple roles in regulating constitutive and alternative
splicing in vivo (Fig. 2D). Sfsr3 homozygous null mutant
embryos fail to form blastocysts, indicating the essential
role of this gene during the initial stages of mouse deve-
lopment (Jumaa et al., 1999).
Enc1 (ectodermal-neural cortex 1) is an actin-binding
protein with Kelch domain known to be up-regulated by
p53 in colorectal cancers and by the beta-catenin/TCF
pathways in HeLa cells (Fig. 2E) (Fujita et al., 2001;
Polyak et al., 1997). Over-expression of Enc1 in
HCT116 colon carcinoma cells results in increased tumor
growth rate (Fujita et al., 2001). Based on its restricted
expression in distal mesenchyme and induction by beta-
catenin/TCF, Enc1 is likely a candidate target of Wnt
genes. Various Wnt family members have been identified
in the distal lung, including Wnt2, Wnt5a (also in the
proximal region), Wnt11 and Wnt7b. Wnt7b is of partic-
ular interest because of the severe lung hypoplasia and
vascular defects reported in knockout mice (Shu et al.,
2002). Wnt7b is expressed in distal epithelial tubules andFig. 3. Expression patterns of genes enriched in the non-branching region (arrowhe
pleiotrophin (Ptn); (D) WW domain-containing protein 2 (Wwp2). Scale bar in Asignals in the mesenchyme via the beta-catenin/TCF
pathway to regulate mesenchymal cell proliferation and
vascular differentiation (Shu et al., 2002; Tebar et al.,
2001).
p38-2G4 (proliferation-associated protein 2G4), the
gene encoding the proliferation-associated nuclear protein
38 kDa, is also restricted to the mesenchyme around distal
buds (Fig. 2F). Little is known about its function. p38-2G4
has potential methionyl aminopeptidase activity. In HeLa
cells, expression of this gene is associated with specific
phases of the cycle (Radomski and Jost, 1995). Its distribu-
tion in the E11.5 lung suggests a selective role in prolifer-
ating distal mesenchymal cells.
Dusp9 (dual-specificity MAPK phosphatase-9 or Mkp-4)
has been shown to inactivate ERK1/2 (extracellular signal-
regulated kinase-1/2) by de-phosphorylation (Fig. 2G)
(Dickinson et al., 2002). Strong Dusp9 mRNA expression
was detected in the peripheral layers of the distal mesen-
chyme near newly formed buds with lower signals in the
interbud region of mesenchyme. These gradients suggest a
dynamic expression pattern and presumably a role in regu-
lating activity of ERK-dependent signals, such as FGF, in
the lung mesenchyme. Based on its localization Dusp9 is
likely a modulator of the Fgf9-Fgfr2c pathway (Colvin et
al., 2001).
Rab7 (Fig. 2H, RAB7, member RAS oncogene family) is a
member of the Rab family of GTPases and vesicle transport
proteins. In Drosophila embryos, rab7 is required for the
establishment of the gradient of decapentaplegic (dpp)
through a transcytosis process. Dpp, the Drosophila homo-
log of the mammalian BMP, is required for proper segmen-
tation of Drosophila embryo (Entchev and Gonzalez-
Gaitan, 2002). In the E11.5 lung Rab7 could play a similar
a role by controlling gradients of Bmp4, which is expressed
by distal epithelial and subepithelial mesenchymal cells
(Weaver et al., 2003).
Group II includes genes expressed in both distal
mesenchyme and epithelium. There are two known genes
(Mucdhl and Dock7) and two ESTs (AK046712, Fig. 2K
and C79329, Fig. 2J) in this group. Mucdhl, the mucin
and cadherin-like gene, has been reported in fetal kidneys
with different spliced isoforms (Fig. 2I) (Goldberg et al.,ads) by whole mount ISH. (A) AK003537; (B) nuclear factor I/X (Nfix); (C)
represents 250 AM.
J. Lu¨ et al. / Developmental Biology 273 (2004) 418–4354282002). Dock7 (dedicator of cytokinesis 7) encodes a
DOCK180-related protein with guanine nucleotide ex-
change activity (Fig. 2L). Dock180 is upstream of thesmall GTPase Rac and has been implicated in Rac-
dependent phagocytosis and cell migration in C. elegans.
Dock180 (Dock1) is also involved in cell migration and
J. Lu¨ et al. / Developmental Biology 273 (2004) 418–435 429invasion in COS-7 cells (Grimsley et al., 2004). Dock7
may have a similar role in controlling cell movements
during distal lung morphogenesis.
Group III consisted of genes with expression restricted
to the distal epithelium. Zdhhc6, Rex3 and an EST
(AK48222) (Figs. 2M–O) are representative of this group.
Zdhhc6 (zinc finger, DHHC domain containing 6) is a
novel transcription factor with DHHC-type zinc finger
domain. Rex3 (reduced expression 3) is also known as
Bex1 (brain expressed X-linked 1) and shares homologous
sequences with Bex2 and Bex3. Bex3, also known as
nerve growth factor receptor associated protein1, plays
a role in nerve growth factor-induced apoptosis (Mukai et
al., 2003). Rex3 is of particular interest because of its
regulation by RA (Faria et al., 1998), and will be
discussed subsequently. Expression of these genes is
likely to be dynamic as the architecture of distal epithelial
structures rapidly changes during branching.
An additional group (group IV), which included CaII
(carbonic anhydrase 2) and Slc4a1 (solute carrier family 4,
member 1) (Figs. 2P and Q), represented the genes
expressed by blood cells. These genes were enriched in
the branching region, likely due to blood cell trapping in the
highly vascular distal lung.
Identification of genes differentially expressed in the
non-branching region
We determined the spatial distribution of four transcripts
enriched in the non-branching region. In situ hybridization
revealed a broad, homogenous distribution of transcripts
throughout the proximal lung and trachea for all genes (Nfix,
Ptn and AV230893) but one (Wwp2).
Nfix (nuclear factor I/X) is a CAAT box binding tran-
scription factor from the Nuclear Factor I (NFI) family (Fig.
3B). Members of this family regulate a variety of other
genes with very diverse functions. For example, Renin, a
regulator of arterial blood pressure, is one of the Nfix targets
(Pan et al., 2004).
Wwp2 (WW domain-containing protein 2) encodes a
Nedd4-like ubiquitin-protein ligase. Nedd4 expression has
been reported in proliferating and prehypertrophic chon-
drocytes during skeletal development (Weston and Under-
hill, 2000); however, no information about Wwp2 is
currently available. We found that Wwp2 transcripts were
restricted to a specific region in the ventral– lateral mesen-
chyme of the trachea and the main bronchi (Fig. 3D and 5).
The similarity of the Wwp2 pattern with that of Rarc in thisFig. 4. Expression and regulation of Tgfbi mRNA in the developing lung. (A) At
(arrowheads); signals are excluded from distal sites, where secondary buds will for
Tgfbi signals are restricted to the proximal mesenchyme of newly formed seconda
stalk of distal lung buds. (D–F) Cultured E11.5 lung at 24 h shows the typical Tgfb
left and E); treatment with TGFh-1 (50 ng/ml) disrupts the localized expression p
right and F). (G–I) By 48 h, the change of Tgfbi pattern induced by TGFh-1 becam
and G. LL, left lung; RL, right lung; V, ventral; D, dorsal; es, esophagus. Scale bregion (Mollard et al., 2000b) suggested that Wwp2 could
be involved in local regulation of RA signaling. We
selected Wwp2 as a candidate gene for further studies
(see below).
Tgfbi is a potential mediator of the TGFb1 effects in the
branching region
Our array analysis revealed Tgfbi (hig-h3, TGF beta
induced), a gene that encodes a cell adhesion-extracellular
matrix protein, significantly enriched in the branching
region. By in situ hybridization we found Tgfbi expres-
sion restricted to the stalk region of distal buds (Fig. 4C).
This localization was consistent with a role in suppressing
local budding. The absence of signals in morphogeneti-
cally more stable proximal regions suggested that Tgfbi
mediated responses and occur only in areas that are
actively branching (Fig. 4C). Although expression of
Tgfbi in the embryonic lung and other organs had been
reported, no systematic analysis of its expression pattern
in developing airways, and its relationship to local sig-
naling was available.
To gain additional insights into the developmental
expression and regulation of Tgfbi by TGFh1, we
extended our analysis to lungs at early stages in vivo
and to cultured lung explants. We found Tgfbi transcripts
in the lung mesenchyme as early as E9.5–10, when
primary buds are forming. In primary lung buds, expres-
sion was excluded from the mesenchyme surrounding the
tips (Fig. 4A). Later at E10.5, Tgfbi transcripts were
localized to regions flanking the nascent secondary buds
(Fig. 4B). This dynamic pattern in regions immediately
proximal to newly formed buds continues through E11–
12, and was also observed in lung cultures (Figs. 4C,
D–I).
Previous studies have shown that in the E11–12 lung
Tgfb1 is transcribed in the subepithelial mesenchyme,
throughout its anterior–posterior axis (Lebeche et al.,
1999; Schmid et al., 1991). However, TGFh1 protein is
accumulated in epithelial–mesenchymal interfaces of the
stalks and clefts (Heine et al., 1990), sites where we found
Tgfbi mRNA expression.
Culturing E11.5 lung explants with exogenous TGFh1
(10–50 ng/ml) resulted in distal expansion of the Tgfbi
mRNA expression domain within 24 h (Fig. 4D right and
F). By 48 h, TGFh1 treatment markedly inhibited lung
growth and branching (Serra et al., 1994), and resulted in
diffuse up-regulation of Tgfbi in the distal mesenchymeE9.5, Tgfbi is expressed in the ventral mesenchyme of primary lung buds
m (asterisks); strong signal are also present in esophagus (es). (B) At E10.5,
ry buds. (C) At E11.5, Tgfbi is seen in mesenchymal cells that surround the
i expression pattern in mesenchymal cells adjacent to stalk of distal buds (D,
attern of Tgfbi and expands Tgfbi expression domain to distal location (D,
e more evident. E, F, H and I are enlarged views of the outlined region in D
ar in C and D represents 175 and 225 AM, respectively.
J. Lu¨ et al. / Developmental Biology 273 (2004) 418–435430(Figs. 4G–I). The widespread distribution of Tgfbi tran-
scripts in TGFh1-treated explants suggested that in the
normal lung, endogenous gradients of TGFh1 restrict
Tgfbi transcription to the stalk region of distal buds
during branching. Whether this represents a direct or an
indirect effect in gene transcription we could not deter-
mine based in our results. Culturing E11.5 lung with
cyclohexamide, to inhibit protein synthesis, markedly
affected the viability of the explants and reproducibility
of the results (data not shown).
Tgfbi has been shown to mediate some of the TGFh1-
related effects in biological processes. These include tumor
suppression, apoptosis and promotion of cell adhesion
(Kim et al., 2003; Zhao et al., 2002a,b, 2003). Studies
in cell lines suggest that, depending on the cell type,
TGFh1 may either induce or prevent apoptosis (Horowitz
et al., 2004). For example, in lung fetal mesenchymal cells
IMR90, which express high levels of Tgfbi, TGFh1
signaling prevents cell death. Interestingly, during early
branching, apoptosis is found predominantly in cleft mes-
enchymal cells (Levesque et al., 2000). This suggests that
activation of the Tgfb1-Tgfbi pathway may help to main-
tain a balance between apoptotic and non-apoptotic sig-
nals, perhaps favoring the latter. In epithelial cell lines,
Tgfbi appears to function as a tumor suppressor gene,
since its down-regulation has been associated with a
tumorigenic phenotype (Zhao et al., 2002a,b, 2003). As
a mediator of cell matrix interactions, Tgfbi has been
shown to bind to various integrins to regulate cell adhe-
sion, migration and proliferation (Bae et al., 2002). Some
of these integrins are present in the developing lung,
where they can be critical for branching, as exemplified
by a3h1 integrin (Kreidberg et al., 1996). Taken together,Fig. 5. Expression pattern of Wwp2 in developing respiratory tract and vertebrate.
E9.5 in mesenchymal cells adjacent to the tracheal epithelium. (B) At E11.5 and (
lateral regions of trachea and main bronchi, where cartilage primordium will form.
level of trachea (tr) and main bronchi (mb) (areas outlined in black) confirmed th
vertebrate (ve) in the E13 embryo. Dashed lines outline the outer surface (blue in
left lung; tr, trachea; mb, main bronchi; D, dorsal; V, ventral; ep, epithelium; ve,these suggest that Tgfbi may be a local modulator of cell
growth and presumably cell survival in specific regions of
branching tubules.
Components of the RA pathway and RA targets were
enriched in the proximal region
Studies using a RARE lacZ reporter mouse have shown
that branching morphogenesis is characterized by down-
regulation of retinoid signaling in distal but not in proximal
regions of respiratory tract (Malpel et al., 2000; Mollard et
al., 2000a). In our screen, we found several known compo-
nents of the RA signaling pathway and RA responsive genes
differentially enriched in the non-branching region, where
RA is maintained active; for example Rarc, cellular RA
binding protein I (Crabp1), stimulated by RA gene 6 (Stra6),
myeloid-associated differentiation marker (Myadm) and
retinal short chain dehydrogenase reductase 1 (Tables 1
and 2; Bouillet et al., 1997; Cui et al., 2001; Rattner et al.,
2000).
Retinoid-related genes were underrepresented in the
branching region. The only RA targets enriched in this
region were either those, such as Hoxb5 and Hoxb6, 5V
genes with low responsiveness to RA, which likely do not
require RA to maintain their expression in the lung (Tables 1
and 2), or genes, such as Rex3, whose expression is down-
regulated by RA signaling. Rex3 was first described in F9
murine teratocarcinoma cells as a gene whose transcription
is inhibited by retinoic acid (Faria et al., 1998). In the E11.5
lung, the presence of Rex3 in the distal epithelium likely
resulted from the local loss of RA activity. This could be
part of a mechanism that allows further development of
distal buds.(A) Low levels of expression of Wwp2 (arrowhead) were first observed at
C) E13, Wwp2 signals were clearly seen in mesenchymal cells of ventral–
Fast Red staining of sections from specimens in B and C (low panel) at the
is pattern. (D) Wwp2 is also expressed in cartilage primordia of developing
A) and epithelium (red in A–C) of the respiratory tract. RL, right lung; LL,
vertebrate; Scale bar in C and D represents 150 and 30 AM, respectively.
al Biology 273 (2004) 418–435 431An ubiquitin ligase potentially associated with Rarc is
differentially expressed in the non-branching region of the
respiratory tract
In eukaryotes, activation of ubiquitin/proteasome-medi-
ated proteolysis allows controlled degradation of regulatory
molecules, including RARs. Ubiquitination is carried out by
at least three classes of enzymes: ubiquitin-activating (E1), -
conjugating (E2) and -protein ligases (E3) enzymes (Cie-
chanover et al., 2000).
One of the most interesting findings of our screen was
the restricted expression of Wwp2, a gene encoding a
Nedd4-like ubiquitin ligase in proximal regions of the
E11.5 respiratory tract. The ventral and ventral– lateral
J. Lu¨ et al. / DevelopmentFig. 6. Expression of Wwp2 and RARg in lung cultures. RA down-regulated Wwp
In 48-h control lung cultures, Wwp2 signals continue to be expressed at sites o
expression. (D and E) Expression of Wwp2 is significantly down-regulated by R
transcripts are expressed in the mesenchyme of the trachea and main bronchi sim
level and distribution of Rarc mRNA. (I) Western blot analysis shows that RARg p
treatment. ct, cartilage precursor. Scale bar in A represents 150 AM.pattern of transcript distribution in tracheal and proximal
lung mesenchyme was highly similar to that described for
Rarc. This became clearer when we analyzed lungs from
E9.5 to E13.5 embryos (Figs. 5A–C) and when we found
Wwp2 transcripts in extra pulmonary Rarc-expressing sites,
such as the vertebral column (Fig. 5D).
Studies in keratinocytes, COS 1 and F9 cells indicate
that ubiquitin-mediated proteolysis regulates endogenous
levels of RARg (Kopf et al., 2000). Moreover, there is
evidence that, at least in some of these cells, RA induces
expression of enzymes of the ubiquitin pathway for
RARg degradation (Kitareewan et al., 2002). This promp-
ted us to investigate the RA regulation of Wwp2 tran-
scription and its relationship to Rar g expression in our2 expression and increased RARg protein level in cultured lungs. (A and B)
f precartilage formation (ct). (C) BMS treatment has no effect on Wwp2
A (10 5 to 10 6 M) in 48-h cultured lungs. (F) In control cultures, Rarc
ilarly as Wwp2. (G and H) RA treatment of lung cultures does not alter the
rotein levels in the proximal region of cultured explants are increased by RA
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reporter mouse up to 72 h with RA (106 to 105 M)
or BMS 493 (106 M)-containing media to enhance or
inhibit retinoid signaling, respectively (Mollard et al.,
2000a; Malpel et al., 2000). Efficacy of treatment was
confirmed by monitoring lacZ expression in these cultures
(Malpel et al., 2000; Rossant et al., 1991, data not
shown). Unexpectedly, we found that endogenous RA is
not required for Wwp2 transcription in proximal airways,
since antagonizing RA signaling did not affect Wwp2
expression (Figs. 6A–C). In turn, exogenous RA signif-
icantly reduced Wwp2 transcription in a concentration-
dependent manner in proximal airways (Figs. 6D, E).
To determine whether these treatments had an impact
in RARg protein or transcripts levels, we performed in
situ hybridization and Western blot analysis of tracheal
and main bronchi regions isolated from these cultures.
Figs. 6F–H confirmed data from previous studies in cell
lines, which showed that RA does not induce Rarc
transcription (Boudjelal et al., 2002; Yamamoto et al.,
2000). We found, however, that levels of RARg protein
were increased in RA treated cultures, as compared to
controls (Fig. 6I). The most likely explanation is that
RARg protein became more stable with the down-regula-
tion of Wwp2 expression. This suggests that, under
physiological conditions, Wwp2-mediated proteolysis con-
tributes to regulate endogenous levels of RARg protein in
the proximal mesenchyme.
The biological relevance of this observation resides in
the fact that the sites where we found Wwp2 expression
corresponded to the regions where Rarc is critical for the
development of cartilage primodium in the respiratory
tract and vertebrae (Figs. 5D and I). Cartilage progenitor
cells require tightly controlled RARg signaling for proper
development. Deletion of the Rarc gene in mice results
in defects in tracheal cartilage ring and anterior axial
skeleton (Lohnes et al., 1993). Moreover, there is in vivo
and in vitro evidence that RARg is critical to mediate
RA teratogenesis and to induce expression of the RA-
metabolizing enzyme, Cyp26a1, when levels of RA
increase to supra-physiological levels (Abu-Abed et al.,
1998). We have previously shown that under similar
conditions, RA treatment of E11.5 explants induces
ectopic Cyp26a1 expression in the tracheal and proximal
lung mesenchyme (Malpel et al., 2000). Interestingly,
these are essentially the same sites where we found Rarc
and Wwp2 transcribed. We propose that down-regulation
of Wwp2 mRNA and induction of Cyp26a1 gene
expression by inappropriately high levels of RA may
be part of a local mechanism that controls RA signaling
and its effects in this region. Our model predicts that
inhibition of Wwp2 expression by excess RA prevents
normal RARg degradation. This ensures that there will be
enough RARg available to mediate the RA teratogenic
responses and to induce Cyp26a1, as an attempt to lower
RA levels.Concluding remarks
In summary, we provide the molecular signature of the
branching and non-branching regions of the E11.5 mouse
respiratory tract. The transcriptional profiles reported here
provide insights into the global trends in gene expression
associated with the developmental events that are typical of
these regions. At E11.5 the distal lung is characterized by
high branching activity, increased growth of both epithelial
and mesenchymal compartments, and plasticity of distal
progenitor cells. We found 83 genes enriched in the distal
region. Many of these genes were associated with cell
proliferation or had a potential link with local known
regulatory pathways, such as the FGF or Wnt. Other genes,
such as splicing factors and translocases, for which we had
no previous information about their role in the distal lung,
could represent, or be part of novel pathways to be inves-
tigated. Our profiling revealed 128 genes enriched in the
proximal respiratory tract region. These included SRY
transcription factors, BMPs, RA-related genes and a large
number of extracellular matrix genes. Several of these genes
have been associated with morphogenetic stability and
formation of proximal mesenchymal derivatives, such as
tracheal cartilage primordia and smooth muscle layers. In
some cases we found representative members of the same
gene family differentially expressed in each region. This
was the case of thrombospondins 1 and 2, respectively, at
distal and proximal sites.
The use of stringent criteria for gene selection and the
complex cellular composition of the samples in our survey
limited our ability to retrieve all important components of
these networks. However, the validity and power of our
approach in identifying potentially relevant genes for further
functional analysis was well supported by our results.
Consistent with this, we confirmed the majority of the
selected genes at the expected location by in situ hybrid-
ization, and we could identify all major patterns of transcript
distribution for both regions. Moreover, our screen was able
to uncover genes, such as Tgfbi and Wwp2, localized to
specific subpopulations of cells, where they are likely
regulating specific developmental events. The database
generated here also represents a valuable resource for
comparisons with similar databases from embryonic kidney,
salivary gland and other branching structures to identify
common regulatory mechanisms.Acknowledgments
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